These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 2005453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
    Oyen WJ, Verhagen C, Saris E, van den Broek WJ, Pieters GF, Corsten FH.
    J Nucl Med; 2000 Apr; 41(4):643-6. PubMed ID: 10768565
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131I with emphasize on the thallium scintigraphy in these subgroups.
    Zakani A, Saghari M, Eftekhari M, Fard-Esfahani A, Fallahi B, Esmaili J, Assadi M.
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1215-21. PubMed ID: 22165686
    [Abstract] [Full Text] [Related]

  • 5. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
    Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ.
    Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
    [Abstract] [Full Text] [Related]

  • 6. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
    Lorberboym M, Murthy S, Mechanick JI, Bergman D, Morris JC, Kim CK.
    J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.
    Iida Y, Hidaka A, Hatabu H, Kasagi K, Konishi J.
    J Nucl Med; 1991 Nov; 32(11):2098-100. PubMed ID: 1941144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G, Fiorentino A, Fragasso G, Fringuelli FM, Todino V.
    Ital J Surg Sci; 1986 Nov; 16(1):11-5. PubMed ID: 3087907
    [Abstract] [Full Text] [Related]

  • 13. Comparison of serum thyroglobulin, 131I and 201Tl scintigraphy in the postoperative follow-up of differentiated thyroid cancer.
    van Sorge-van Boxtel RA, van Eck-Smit BL, Goslings BM.
    Nucl Med Commun; 1993 May; 14(5):365-72. PubMed ID: 8510876
    [Abstract] [Full Text] [Related]

  • 14. 201ti scintigraphy in postoperative detection of thyroid cancer: a comparative study with 131i.
    Tonami N, Hisada K.
    Radiology; 1980 Aug; 136(2):461-4. PubMed ID: 7403524
    [Abstract] [Full Text] [Related]

  • 15. Routine 201Tl scintigraphy in the follow-up of patients with differentiated thyroid carcinoma: diagnostic accuracy and clinical impact.
    Hsu CC, Chen YW, Huang YF, Chuang YW.
    Nucl Med Commun; 2007 Sep; 28(9):681-7. PubMed ID: 17667746
    [Abstract] [Full Text] [Related]

  • 16. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer.
    Roelants V, Nayer PD, Bouckaert A, Beckers C.
    Eur J Nucl Med; 1997 Jul; 24(7):722-7. PubMed ID: 9211756
    [Abstract] [Full Text] [Related]

  • 17. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM, Kim ES, Ryu JS, Hong SJ, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
    Reiners C, Reimann J, Schäffer R, Baum K, Becker W, Eilles C, Gerhards W, Schick F, Spiegel W, Wiedemann W.
    Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
    [Abstract] [Full Text] [Related]

  • 20. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma.
    Lindegaard MW, Paus E, Høie J, Kullman G, Stenwig AE.
    Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.